185 related articles for article (PubMed ID: 31358728)
1. RACK1 interaction with c-Src is essential for osteoclast function.
Park JH; Jeong E; Lin J; Ko R; Kim JH; Yi S; Choi Y; Kang IC; Lee D; Lee SY
Exp Mol Med; 2019 Jul; 51(7):1-9. PubMed ID: 31358728
[TBL] [Abstract][Full Text] [Related]
2. The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.
Lin J; Lee D; Choi Y; Lee SY
Sci Signal; 2015 Jun; 8(379):ra54. PubMed ID: 26038599
[TBL] [Abstract][Full Text] [Related]
3. c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton.
Izawa T; Zou W; Chappel JC; Ashley JW; Feng X; Teitelbaum SL
Mol Cell Biol; 2012 Jul; 32(14):2943-53. PubMed ID: 22615494
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid.
Ariyoshi W; Takahashi T; Kanno T; Ichimiya H; Takano H; Koseki T; Nishihara T
J Biol Chem; 2005 May; 280(19):18967-72. PubMed ID: 15757905
[TBL] [Abstract][Full Text] [Related]
5. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
6. The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.
Kim HJ; Zhang K; Zhang L; Ross FP; Teitelbaum SL; Faccio R
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2325-30. PubMed ID: 19171907
[TBL] [Abstract][Full Text] [Related]
7. Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas.
Kobayakawa M; Matsubara T; Mizokami A; Hiura F; Takakura N; Kokabu S; Matsuda M; Yasuda H; Nakamura I; Takei Y; Honda H; Hosokawa R; Jimi E
Cell Biochem Funct; 2020 Apr; 38(3):300-308. PubMed ID: 31887784
[TBL] [Abstract][Full Text] [Related]
8. The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.
Adapala NS; Barbe MF; Langdon WY; Nakamura MC; Tsygankov AY; Sanjay A
J Biol Chem; 2010 Nov; 285(47):36745-58. PubMed ID: 20851882
[TBL] [Abstract][Full Text] [Related]
9. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
[TBL] [Abstract][Full Text] [Related]
10. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
11. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
12. The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1.
Chang BY; Chiang M; Cartwright CA
J Biol Chem; 2001 Jun; 276(23):20346-56. PubMed ID: 11279199
[TBL] [Abstract][Full Text] [Related]
13. Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation.
Matsubara T; Addison WN; Kokabu S; Neff L; Horne W; Gori F; Baron R
J Biol Chem; 2021; 296():100790. PubMed ID: 34019873
[TBL] [Abstract][Full Text] [Related]
14. RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251.
Kiely PA; Leahy M; O'Gorman D; O'Connor R
J Biol Chem; 2005 Mar; 280(9):7624-33. PubMed ID: 15611085
[TBL] [Abstract][Full Text] [Related]
15. Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis.
Deepak V; Kruger MC; Joubert A; Coetzee M
Biofactors; 2015; 41(6):403-13. PubMed ID: 26627060
[TBL] [Abstract][Full Text] [Related]
16. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.
Lee SY; Lee KS; Yi SH; Kook SH; Lee JC
PLoS One; 2013; 8(12):e80873. PubMed ID: 24324641
[TBL] [Abstract][Full Text] [Related]
17. c-Src control of chloride channel support for osteoclast HCl transport and bone resorption.
Edwards JC; Cohen C; Xu W; Schlesinger PH
J Biol Chem; 2006 Sep; 281(38):28011-22. PubMed ID: 16831863
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
19. Rack1 mediates Src binding to drug transporter P-glycoprotein and modulates its activity through regulating Caveolin-1 phosphorylation in breast cancer cells.
Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
Cell Death Dis; 2019 May; 10(6):394. PubMed ID: 31113938
[TBL] [Abstract][Full Text] [Related]
20. Src kinase activity is essential for osteoclast function.
Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
